Biotech

All Articles

Innovent links cytokine to intestines cancer cells responses

.Innovent Biologics has actually produced the case that its gate inhibitor-cytokine combination prot...

Merck, Daiichi ADC reaches goal in phase 3 lung cancer research study

.A stage 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) h...

Rakovina deepens AI focus with collab to choose cancer cells aim ats

.5 months after Rakovina Therapeutics turned towards artificial intelligence, the cancer-focused bio...

Ascendis' dwarfism drug hits in phase 3, endangers BioMarin

.Ascendis Pharma has actually become a potential threat to BioMarin's Voxzogo, reporting stage 3 gro...

Despite ph. 3 miss, Alkeus views road ahead of time for eye health condition resource

.Though Alkeus Pharmaceuticals' dental eye illness property failed to substantially reduce geographi...

Kairos goes public along with $6M IPO to finance trials of cancer cells medication

.Along with a trio of biotechs hitting the Nasdaq on Friday, it was quick and easy to overlook a sma...

Vaccine and Keytruda combo effective in squamous tissue cancer

.Immune checkpoint preventions are the superheroes of cancer therapy. Medications like Bristol Myers...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of notable management hirings, shootings and ...

Regeneron's Opdualag competitor shows 57% response fee

.Regeneron is back along with long-term follow-up for its own LAG-3 inhibitor and also PD-1 inhibito...

AstraZeneca posts records on internal competitors to AbbVie, Pfizer ADCs

.AstraZeneca has actually discussed a very early examine the functionality of its own internal antib...